期刊
CELLULAR ONCOLOGY
卷 44, 期 1, 页码 179-192出版社
SPRINGER
DOI: 10.1007/s13402-020-00560-2
关键词
gastric cancer; SNHG3; stem cell; cisplatin resistance; miR-3619-5p
资金
- Shanghai Anticancer Association aoxiang Project [SACA-AX201901]
Our study revealed that IL-6 triggers stem cell-like properties in cisplatin-treated gastric cancer cells by activating STAT3, which in turn transcriptionally regulates SNHG3 expression. Up-regulation of SNHG3 expression positively correlates with cisplatin resistance and stemness of gastric cancer cells, while down-regulation inhibits stem cell-like properties. Additionally, SNHG3 up-regulates ARL2 expression through sponging miR-3619-5p, which plays a predominant role in mediating the oncogenic properties of SNHG3 in this disease.
Background Chemotherapy is, next to surgery and radiotherapy, the mainstay regimen for the clinical management of gastric cancer. This therapy is, however, heavily compromised by the acquisition of resistance. Here, we aimed to clarify the potential involvement of long non-coding RNA SNGH3 in the acquisition of cisplatin resistance and stemness in gastric cancer. Methods Cell viability and proliferation were measured using Cell Counting Kit-8 and colony formation assays, respectively. Stem cell-like cell growth was evaluated using a mammosphere formation assay. RNA levels of SNHG2, OCT-4, SOX-2, CD44, miR-3619-5p and ARL2 were determined using qRT-PCR, whereas protein levels of OCT-4, SOX-2, CD44, ARL2, STAT3 and pSTAT3 were determined using Western blotting. Dual luciferase reporter assays were employed to interrogate regulatory interactions between STAT3, SNHG3, miR-3619-5p and ARL2, respectively. Direct binding of STAT3 to the SNHG3 promoter was investigated using a chromatin immunoprecipitation assay. Results We found that IL-6 triggered stem cell-like properties in cisplatin-treated gastric cancer cells and activated STAT3, which in turn transcriptionally regulated SNHG3 expression. SNHG3 expression up-regulation positively correlated with cisplatin resistance and stemness of gastric cancer cells, while SNHG3 down-regulation inhibited stem cell-like properties. In addition, we found that SNHG3 up-regulated ARL2 expression through sponging miR-3619-5p, which predominantly mediated the oncogenic properties of SNHG3 in this disease. Conclusions Our data indicate an involvement of aberrant SNHG3 over-expression in the acquisition of both cisplatin resistance and stemness of gastric cancer cells, and of the IL-6/STAT3/SNHG3/miR-3619-5p/ARL2 signaling cascade in the oncogenic properties of SNHG3.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据